Molecular Biology of the Cell click for ASCB 2009 Annual Meeting page

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

Originally published as MBC in Press, 10.1091/mbc.E02-02-0063 on July 11, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Tables 1 and 2
Right arrow All Versions of this Article:
E02-02-0063v1
13/9/3055    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishihara, A.
Right arrow Articles by Miyazono, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishihara, A.
Right arrow Articles by Miyazono, K.

Vol. 13, Issue 9, 3055-3063, September 2002

Functional Heterogeneity of Bone Morphogenetic Protein Receptor-II Mutants Found in Patients with Primary Pulmonary Hypertension

Ayako Nishihara,*dagger Tetsuro Watabe,* Takeshi Imamura,Dagger and Kohei MiyazonoDagger §

 *Department of Molecular Pathology, Graduate School of Medicine, University of Tokyo, Tokyo 113-0033, Japan;  dagger Laboratory of Cell Signaling, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8549, Japan; and  Dagger Department of Biochemistry, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo 170-8455, Japan

Germline mutations in the BMPR2 gene encoding bone morphogenetic protein (BMP) type II receptor (BMPR-II) have been reported in patients with primary pulmonary hypertension (PPH), but the contribution of various types of mutations found in PPH to the pathogenesis of clinical phenotypes has not been elucidated. To determine the biological activities of these mutants, we performed functional assays testing their abilities to transduce BMP signals. We found that the reported missense mutations within the extracellular and kinase domains of BMPR-II abrogated their signal-transducing abilities. BMPR-II proteins containing mutations at the conserved cysteine residues in the extracellular and kinase domains were detected in the cytoplasm, suggesting that the loss of signaling ability of certain BMPR-II mutants is due at least in part to their altered subcellular localization. In contrast, BMPR-II mutants with truncation of the cytoplasmic tail retained the ability to transduce BMP signals. The differences in biological activities among the BMPR-II mutants observed thus suggest that additional genetic and/or environmental factors may play critical roles in the pathogenesis of PPH.

§ Corresponding author. E-mail address: miyazono-ind{at}umin.ac.jp.

Molecular Biology of the Cell
Vol. 13, 3055-3063, September 2002
Copyright © 2002 by The American Society for Cell Biology


This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
R. D. Machado, O. Eickelberg, C. G. Elliott, M. W. Geraci, M. Hanaoka, J. E. Loyd, J. H. Newman, J. A. Phillips III, F. Soubrier, R. C. Trembath, et al.
Genetics and genomics of pulmonary arterial hypertension.
J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S32 - S42.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
M Shintani, H Yagi, T Nakayama, T Saji, and R Matsuoka
A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension
J. Med. Genet., May 1, 2009; 46(5): 331 - 337.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. West, J. Harral, K. Lane, Y. Deng, B. Ickes, D. Crona, S. Albu, D. Stewart, and K. Fagan
Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions
Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L744 - L755.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
A. Sobolewski, N. Rudarakanchana, P. D. Upton, J. Yang, T. K. Crilley, R. C. Trembath, and N. W. Morrell
Failure of bone morphogenetic protein receptor trafficking in pulmonary arterial hypertension: potential for rescue
Hum. Mol. Genet., October 15, 2008; 17(20): 3180 - 3190.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. T. Nasim, A. Ghouri, B. Patel, V. James, N. Rudarakanchana, N. W. Morrell, and R. C. Trembath
Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertension
Hum. Mol. Genet., June 1, 2008; 17(11): 1683 - 1694.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. B. Yu, D. Y. Deng, H. Beppu, C. C. Hong, C. Lai, S. A. Hoyng, N. Kawai, and K. D. Bloch
Bone Morphogenetic Protein (BMP) Type II Receptor Is Required for BMP-mediated Growth Arrest and Differentiation in Pulmonary Artery Smooth Muscle Cells
J. Biol. Chem., February 15, 2008; 283(7): 3877 - 3888.
[Abstract] [Full Text] [PDF]

Home page
 J BiochemHome page
Y. Suzuki, K. Montagne, A. Nishihara, T. Watabe, and K. Miyazono
BMPs Promote Proliferation and Migration of Endothelial Cells via Stimulation of VEGF-A/VEGFR2 and Angiopoietin-1/Tie2 Signalling
J. Biochem., February 1, 2008; 143(2): 199 - 206.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Lagna, M. M. Ku, P. H. Nguyen, N. A. Neuman, B. N. Davis, and A. Hata
Control of Phenotypic Plasticity of Smooth Muscle Cells by Bone Morphogenetic Protein Signaling through the Myocardin-related Transcription Factors
J. Biol. Chem., December 21, 2007; 282(51): 37244 - 37255.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
Z. Wen, L. Han, J. R. Bamburg, S. Shim, G.-l. Ming, and J. Q. Zheng
BMP gradients steer nerve growth cones by a balancing act of LIM kinase and Slingshot phosphatase on ADF/cofilin
J. Cell Biol., October 3, 2007; 178(1): 107 - 119.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. C. Chan, P. H. Nguyen, B. N. Davis, N. Ohoka, H. Hayashi, K. Du, G. Lagna, and A. Hata
A Novel Regulatory Mechanism of the Bone Morphogenetic Protein (BMP) Signaling Pathway Involving the Carboxyl-Terminal Tail Domain of BMP Type II Receptor
Mol. Cell. Biol., August 15, 2007; 27(16): 5776 - 5789.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
P. B. Sehgal and S. Mukhopadhyay
Dysfunctional Intracellular Trafficking in the Pathobiology of Pulmonary Arterial Hypertension
Am. J. Respir. Cell Mol. Biol., July 1, 2007; 37(1): 31 - 37.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
P. B. Sehgal and S. Mukhopadhyay
Pulmonary arterial hypertension: a disease of tethers, SNAREs and SNAPs?
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H77 - H85.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. Zakrzewicz, M. Hecker, L. M. Marsh, G. Kwapiszewska, B. Nejman, L. Long, W. Seeger, R. T. Schermuly, N. W. Morrell, R. E. Morty, et al.
Receptor for Activated C-Kinase 1, a Novel Interaction Partner of Type II Bone Morphogenetic Protein Receptor, Regulates Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension
Circulation, June 12, 2007; 115(23): 2957 - 2968.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
R. E. Morty, B. Nejman, G. Kwapiszewska, M. Hecker, A. Zakrzewicz, F. M. Kouri, D. M. Peters, R. Dumitrascu, W. Seeger, P. Knaus, et al.
Dysregulated Bone Morphogenetic Protein Signaling in Monocrotaline-Induced Pulmonary Arterial Hypertension
Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1072 - 1078.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
N. W. Morrell
Pulmonary Hypertension Due to BMPR2 Mutation: A New Paradigm for Tissue Remodeling?
Proceedings of the ATS, November 1, 2006; 3(8): 680 - 686.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. I. Said
Mediators and modulators of pulmonary arterial hypertension
Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L547 - L558.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
X. Wu, M. S. Chang, S. A. Mitsialis, and S. Kourembanas
Hypoxia Regulates Bone Morphogenetic Protein Signaling Through C-Terminal-Binding Protein 1
Circ. Res., August 4, 2006; 99(3): 240 - 247.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
T. Miyoshi, F. Otsuka, J. Suzuki, M. Takeda, K. Inagaki, Y. Kano, H. Otani, Y. Mimura, T. Ogura, and H. Makino
Mutual Regulation of Follicle-Stimulating Hormone Signaling and Bone Morphogenetic Protein System in Human Granulosa Cells
Biol Reprod, June 1, 2006; 74(6): 1073 - 1082.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
W. K. P. Wong, J. A. Knowles, and J. H. Morse
Bone Morphogenetic Protein Receptor Type II C-Terminus Interacts with c-Src: Implication for a Role in Pulmonary Arterial Hypertension
Am. J. Respir. Cell Mol. Biol., November 1, 2005; 33(5): 438 - 446.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. B. Yu, H. Beppu, N. Kawai, E. Li, and K. D. Bloch
Bone Morphogenetic Protein (BMP) Type II Receptor Deletion Reveals BMP Ligand-specific Gain of Signaling in Pulmonary Artery Smooth Muscle Cells
J. Biol. Chem., July 1, 2005; 280(26): 24443 - 24450.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
R. D. Machado, V. James, M. Southwood, R. E. Harrison, C. Atkinson, S. Stewart, N. W. Morrell, R. C. Trembath, and M. A. Aldred
Investigation of Second Genetic Hits at the BMPR2 Locus as a Modulator of Disease Progression in Familial Pulmonary Arterial Hypertension
Circulation, February 8, 2005; 111(5): 607 - 613.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
T. Satoh, K. Kimura, Y. Okano, M. Hirakata, Y. Kawakami, and M. Kuwana
Lack of circulating autoantibodies to bone morphogenetic protein receptor-II or activin receptor-like kinase 1 in mixed connective tissue disease patients with pulmonary arterial hypertension
Rheumatology, February 1, 2005; 44(2): 192 - 196.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. Beppu, F. Ichinose, N. Kawai, R. C. Jones, P. B. Yu, W. M. Zapol, K. Miyazono, E. Li, and K. D. Bloch
BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia
Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1241 - L1247.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Takeda, F. Otsuka, K. Nakamura, K. Inagaki, J. Suzuki, D. Miura, H. Fujio, H. Matsubara, H. Date, T. Ohe, et al.
Characterization of the Bone Morphogenetic Protein (BMP) System in Human Pulmonary Arterial Smooth Muscle Cells Isolated from a Sporadic Case of Primary Pulmonary Hypertension: Roles of BMP Type IB Receptor (Activin Receptor-Like Kinase-6) in the Mitotic Action
Endocrinology, September 1, 2004; 145(9): 4344 - 4354.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
T. Watabe, A. Nishihara, K. Mishima, J. Yamashita, K. Shimizu, K. Miyazawa, S.-I. Nishikawa, and K. Miyazono
TGF-{beta} receptor kinase inhibitor enhances growth and integrity of embryonic stem cell-derived endothelial cells
J. Cell Biol., December 22, 2003; 163(6): 1303 - 1311.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
R. D. Machado, N. Rudarakanchana, C. Atkinson, J. A. Flanagan, R. Harrison, N. W. Morrell, and R. C. Trembath
Functional interaction between BMPR-II and Tctex-1, a light chain of Dynein, is isoform-specific and disrupted by mutations underlying primary pulmonary hypertension
Hum. Mol. Genet., December 15, 2003; 12(24): 3277 - 3286.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
O. Eickelberg, M. E Yeager, and F. Grimminger
The tantalizing triplet of pulmonary hypertension--BMP receptors, serotonin receptors, and angiopoietins
Cardiovasc Res, December 1, 2003; 60(3): 465 - 467.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Matsuyama, M. Iwadate, M. Kondo, M. Saitoh, A. Hanyu, K. Shimizu, H. Aburatani, H. K. Mishima, T. Imamura, K. Miyazono, et al.
SB-431542 and Gleevec Inhibit Transforming Growth Factor-{beta}-Induced Proliferation of Human Osteosarcoma Cells
Cancer Res., November 15, 2003; 63(22): 7791 - 7798.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
V. C. Foletta, M. A. Lim, J. Soosairajah, A. P. Kelly, E. G. Stanley, M. Shannon, W. He, S. Das, J. Massague, and O. Bernard
Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1
J. Cell Biol., September 15, 2003; 162(6): 1089 - 1098.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. R. Runo, C. L. Vnencak-Jones, M. Prince, J. E. Loyd, L. Wheeler, I. M. Robbins, K. B. Lane, J. H. Newman, J. Johnson, W. C. Nichols, et al.
Pulmonary Veno-occlusive Disease Caused by an Inherited Mutation in Bone Morphogenetic Protein Receptor II
Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 889 - 894.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]